Regulation of oocyte donation to women over the age of 50: A question of reproductive choice
- Cite this article as:
- Paulson, R.J. & Sauer, M.V. J Assist Reprod Genet (1994) 11: 177. doi:10.1007/BF02211804
- 46 Downloads
As in most situations involving medial ethics, we believe that it is best to individualize. Categorical exclusions or rules preclude the possibility of individual histories or details which may be sufficiently compelling to overrule the rationale used to establish the rules in the first place. We believe that no medical therapy should be categorically denied to any subgroup of the population based on age alone, including oocyte donation. Individuals should be able to seek assistance and have available to them the full spectrum of medical knowledge and technology. As with any new form of therapy, the exact risks or long-term consequences remain unknown. Accordingly, this method should be applied only under carefully controlled protocols, preferably approved by local institutional review boards. Only in this manner can we hope to collect data which will eventually lead to a better understanding of the efficacy and clinical utility of this treatment. The establishment of reasonable guidelines, not absolute rules, regarding any form of medical therapy including oocyte donation should be based on scientific knowledge, not politics.